Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in

S Dehghan1, M Hesaraki2, M Soleimani3

  • 1Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Neuroscience
|January 26, 2016
PubMed

Insights

Valproic acid and Oct4 expression promote myelin repair in demyelinated brains by converting cells into myelinating oligodendrocytes, offering a promising therapeutic strategy for multiple sclerosis.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • Multiple sclerosis involves demyelination and neurological deficits.
  • Spontaneous remyelination is limited and often fails.
  • Transcription factors can reprogram somatic cells into neural progenitors.

Purpose of the Study:

  • To investigate the effect of valproic acid (VPA) and Oct4 transcription factor on experimental demyelination.
  • To assess the potential of VPA and Oct4 to enhance myelin repair in the adult brain.

Main Methods:

  • Mice received VPA, followed by lentiviral Oct4 expression induction.
  • Lysolecithin-induced demyelination was induced in the optic chiasm.
  • Functional recovery (VEP), myelination (FluoroMyelin, PLP), and cell lineage (Oct4, SSEA1, Olig2, Sox10) were assessed.

Main Results:

  • VPA + Oct4 treatment accelerated VEP recovery and enhanced myelination.
  • Increased numbers of Sox10+ and myelinating cells were observed.
  • Transdifferentiation of Oct4-transfected cells into myelinating oligodendrocytes was confirmed.

Conclusions:

  • VPA and Oct4 administration promote myelin repair by inducing cell transdifferentiation into oligodendrocytes.
  • This approach shows promise for enhancing myelin repair in adult brains affected by demyelinating diseases.

Related Concept Videos